---
title: "Hualan Vac released its 2024 annual performance, with a net profit attributable to the parent company of 206 million yuan, a decrease of 76.10%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233631061.md"
description: "Hualan Vac released its 2024 annual report, with operating revenue of 1.128 billion yuan, a year-on-year decrease of 53.21%; net profit attributable to shareholders was 206 million yuan, a year-on-year decline of 76.10%. After deducting non-recurring gains and losses, the net profit was 120 million yuan, a year-on-year decrease of 84.12%. The basic earnings per share were 0.3436 yuan, and it plans to distribute a cash dividend of 2 yuan (including tax) for every 10 shares to all shareholders"
datetime: "2025-03-28T12:13:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233631061.md)
  - [en](https://longbridge.com/en/news/233631061.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233631061.md)
---

# Hualan Vac released its 2024 annual performance, with a net profit attributable to the parent company of 206 million yuan, a decrease of 76.10%

According to the Zhitong Finance APP, Hualan Vac (301207.SZ) released its annual report for 2024, showing an operating income of 1.128 billion yuan, a year-on-year decrease of 53.21%. The net profit attributable to shareholders of the listed company was 206 million yuan, a year-on-year decrease of 76.10%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 120 million yuan, a year-on-year decrease of 84.12%. The basic earnings per share were 0.3436 yuan. In addition, it plans to distribute a cash dividend of 2 yuan (including tax) for every 10 shares to all shareholders

### Related Stocks

- [301207.CN](https://longbridge.com/en/quote/301207.CN.md)

## Related News & Research

- [15:44 ETPiramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited](https://longbridge.com/en/news/296263336.md)
- [Piramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited](https://longbridge.com/en/news/296263228.md)
- [15:36 ETPiramal Pharma Limited Completes Acquisition of Controlling Stake in Yapan Bio Private Limited](https://longbridge.com/en/news/296262881.md)
- [Acosta Verde launches subscription rights offering to raise up to MXN 1.09 billion](https://longbridge.com/en/news/295976470.md)
- [BREAKINGVIEWS-Trumps laugh all the way to the bank charter](https://longbridge.com/en/news/296136268.md)